Nemaura Medical is a holding company. Through its subsidiaries, Co. performs medical device research and manufacturing of a continuous glucose monitoring system, named sugarBEAT®. The sugarBEAT® device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients. The sugarBEAT® device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. SugarBEAT® consists of a disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter. We show 25 historical shares outstanding datapoints in our NMRD shares outstanding history coverage, used to compute NMRD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NMRD market cap history over the course of time is important for investors
interested in comparing NMRD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NMRD versus a peer is one thing; comparing
NMRD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NMRD can fluctuate over the course of history.
With this page we aim to empower investors researching NMRD by allowing them to research the NMRD market cap history. |
Free NMRD Email Alerts:
Video: The Importance of Market Cap
